Skip to content

CVS Health reaffirms full year adjusted EPS guidance ahead of investor meetings

September 15, 2020

CVS Health (NYSE:CVS) expects FY20 Adj. EPS of $7.14-$7.27 – same as previously expected, but at the midpoint shy of consensus forecasts for $7.23.

GAAP EPS guidance is trimmed from $5.59-$5.72 to $5.16-$5.29, thanks to charges on early payback of debt in Q3.

Cash flow from operations is still seen at $11B-$11.5B.

The company is presenting later today at the Morgan Stanley Global Healthcare Conference. Webcast here.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: